Consensus price target for (NASDAQ:LNSR) remains steady at $10, reflecting stable analyst outlook. Earnings reports and advancements in the LENSAR Laser System are crucial factors influencing stock performance. Market trends and partnerships play a significant role in shaping LENSAR's growth prospects and analyst sentiment. LENSAR, Inc. (NASDAQ:LNSR) is a medical device company that focuses on developing and marketing the LENSAR Laser System. This system is used for cataract treatment and managing corneal ...